MTOR and head and neck squamous cell carcinoma: Zhou et al. [47] found that HSPA12B secretion from tumor-associated endothelial cells activates the PI3K/AKT/mTOR pathway in HUVECs, promoting an immunosuppressive microenvironment in head and neck squamous cell carcinoma.